Pharmaron - About the company
Pharmaron is a public company based in Beijing (China), founded in 2003 by Bei Zheng, Larry Lou and Boliang Lou. It operates as a Suite of drug discovery and development services for small molecules. Pharmaron has raised $320M in funding from Legend Capital and Gl-investment.
Company Details
Pharmaron offers a suite of drug discovery and development services for small molecules, nucleosides, nucleotides, peptides, lipids and carbohydrates. They offer their R&D services across a number of disciplines including chemistry, biology, DMPK, pharmacology, toxicology and chemical and formulation development. The company claims that their chemistry division is one of the largest chemistry service providers in the world with experience and expertise in organic synthesis, library/high-throughput synthesis, chiral chemistry, medicinal, computational and cheminformatics, bioorganic chemistry, process and scale-up, analytical and purification. Their biologics division offers services such as antibody/protein engineering, antibody humanization, cell line development, recombinant antibody production, protein expression, purification, and characterization.The company has acquired Xceleron and SNBL CPC to augment its offerings.
- Website
- www.pharmaron.com
- Registered Address
- Baltimore, Maryland
Key Metrics
Founded Year
2003
Location
Beijing, China
Stage
Public
Total Funding
$320M in 5 rounds
Latest Funding Round
Investors
Annual Revenue
$1B+ as on Dec 31, 2025
Employee Count
10,000 - 1,000,000 as on Mar 01, 2026
Exit Details
Public
Legal entities associated with Pharmaron
Pharmaron is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
PHARMARON INC CIN: 208419781 , United States, Active | Dec 31, 1999 | - | 741 (As on Dec 31, 2024) | - |
Pharmaron Manufacturing Services (uk) Ltd CIN: 5188033 , United Kingdom, Active | Jul 22, 2004 | £1M - £10M (As on Dec 31, 2024) | 138 (As on Dec 31, 2024) | |
Pharmaron Beijing Co., Ltd. CIN: 9111030276350109XG , China, Active | Jul 01, 2004 | $1B+ (As on Dec 31, 2025) | - | - |
Pharmaron's IPO details
Pharmaron got listed on Feb 01, 2019.
Click here to take a look at Pharmaron's IPO in detail
Sign up to download Pharmaron's company profile
Pharmaron's funding and investors
Pharmaron has raised a total funding of $320M over 5 rounds. Its first funding round was on Sep 20, 2008. Its latest funding round was a PE round on Dec 14, 2015 for $*****. 2 investors participated in its latest round. Pharmaron has 13 institutional investors.
Here is the list of recent funding rounds of Pharmaron:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 14, 2015 | 2790058 | PE | 9972001 | 8786079 | 8126257 | 8305751 |
Mar 01, 2011 | 4336209 | Series C | 7725631 | 9996423 | 6499270 | |
Sep 25, 2009 | 3187108 | Grant (prize money) | 6752260 | 3741580 | 3586145 |
View details of Pharmaron's funding rounds and investors
Pharmaron's founders and board of directors
Founder? Claim ProfileThe founders of Pharmaron are Bei Zheng, Larry Lou and Boliang Lou. Boliang Lou is the CEO of Pharmaron.
Here are the details of Pharmaron's key team members:
- Bei Zheng: Co-Founder of Pharmaron. Contact Info: 1 email address
- Larry Lou: Co-Founder of Pharmaron. Contact Info: 1 email address
- Boliang Lou: Co-Founder & CEO of Pharmaron. Contact Info: 1 email address
View details of Pharmaron's Founder profiles and Board Members
Pharmaron's employee count trend
Pharmaron has 10,000 - 1,000,000 employees as of Mar 26. Here is Pharmaron's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Pharmaron's Investments and acquisitions
Pharmaron has made 4 investments in companies including SocialMED and Eclincloud. Pharmaron has also acquired 5 companies including Biortus and Aesica.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Oct 28, 2025 | Acquisition | 2009 | Wuxi (China) | |
Jan 10, 2023 | Acquisition | 2004 | Newcastle Upon Tyne (United Kingdom) | |
Oct 08, 2022 | Investments | 2017 |
See all investments and acquisitions by Pharmaron
News related to Pharmaron
Media has covered Pharmaron for a total of 2 events in the last 1 year.
•
•
BridGene Biosciences Raises $28M in Series B+ FundingFinSMEs•Oct 16, 2025•Lapam Capital, GTJAI, BridGene Biosciences, Proxima Ventures and 3 others
•
TheraCryf partners with Pharmaron to develop addiction programmeMorningstar•May 12, 2025•TheraCryf, Pharmaron
•
CN Bio and Pharmaron Establish Long-Term Strategic PartnershipBusiness Wire•Apr 24, 2025•Pharmaron, CN Bio
•
•
CN Bio Raises $21 Million Series B FinancingEuropean Pharmaceutical Manufacturer•Apr 23, 2024•CN Bio, Pharmaron, CN Innovations
•
Pharmaron’s net profit in 2023 is 1.6 billion yuan: a year-on-year increase of 16.48%PencilNews•Mar 28, 2024•Pharmaron
•
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEAACN Newswire•Jan 02, 2024•China Medical System, Rxilient, Pharmaron, HealthifyMe and 1 other
•
•
Pharmaron Starts Work on U.K. Cell & Gene Therapy PlantIndustrial Info Resources•Apr 18, 2023•Pharmaron
Are you a Founder ?
FAQs about Pharmaron
Explore our recently published companies
- Otzarreta Think And Make - Gipuzkoa based, 1970 founded, Unfunded company
- Accelerate360Canada - Burlington based, 1969 founded, Acquired company
- Mabsolutions - Darmstadt based, Funding Raised company
- Synscribe - Singapore based, 2025 founded, Unfunded company
- Native Ecology - Denver based, 2000 founded, Funding Raised company
- MackyClyde SEO - Bangsar based, 2020 founded, Unfunded company

